Timothy Phares, Ph.D. |
|
 |
Dr. Phares received his undergraduate degree in Biology from Youngstown State University in 1999. In 2007 he received a PhD in Immunology and Microbial Pathogenesis from Thomas Jefferson University. As a Research Associate his studies have focused on elucidating the consequences of inhibitory ligand upregulation by resident CNS cell populations on T cell immunity during viral infections. |
Carine Savarin, Ph.D. |
|
|
Dr. Savarin received her PhD in 2006 from the Claude Bernard University in Lyon, France. As a Research Associate she is currently investigating the effector functions of neutrophils and monocytes recruited to the central nervous system in the coronavirus model of virus-induced demyelination. In addition she is studying the interplay between neutrophils and T cell function in contributing to central nervous system disease. |
Niranjan Butchi, Ph.D. |
|
|
Dr. Butchi is a Postdoctoral Fellow. He received his PhD in Neuroimmunology from the Louisiana State University in 2010, after spending the last year of his graduate research at the Rocky Mountain Laboratories/NIH. His postdoctoral research is focused on the action of type I interferons on resident glia cells and neurons during virus induced encephalitis. Particular focus is placed on antiviral mechanisms in distinct cell types. |
Parul Kapil, M.S. |
|
|
Mrs Kapil earned her MS from the Gurukul Kangri Vishwavidyalaya University in India. She is a Predoctoral Student at Cleveland State University and her research project focuses on the roles of innate anti-viral effector molecules specifically 2-5A-dependent ribonuclease L (RNaseL) and RNA-dependent protein kinase (PKR) in stemming viral spread and pathology during viral induced demyelination. |
Mi Widness |
|
|
Mrs Widness is a senior research technologist who is responsible for mouse breeding and assists in isolation of glial cells from the CNS and genetic profiling. |
